Stamford, CT -- (SBWIRE) -- 08/14/2013 -- High Rising Stocks provides investors with the hot penny stock alerts on a regular basis. We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: HEMP, INC. (OTCMKTS:HEMP), Affymax, Inc.(NASDAQ:AFFY), Nuvilex Inc (OTCMKTS:NVLX), Elite Pharmaceuticals Inc (OTCBB:ELTP)
HEMP, INC. (OTCMKTS:HEMP) shares dropped 6.25% and closed at $0.0150. The company on July 18 said it feels it is necessary to inform and educate shareholders, and others who may be misinformed, on the difference between Industrial Hemp and marijuana. It is important to note that Industrial Hemp products are completely legal for consumers to purchase in the United States.
Additionally, the company on July 8 announces its first $200,000 sale after inking an exclusive agreement with CleanPath Resources Corp. (CLNP). This agreement is for CleanPath to distribute Hemp, Inc.'s life-changing nutraceutical, "Focus™", which is designed to support "Clearer Thinking" and "Improve Memory". According to Hemp, Inc. (HEMP) executives, the company has already collected over $200,000 of income in "Focus™" sales from CleanPath.
Should Investors Rush To Buy HEMP After The Solid Rally? Get Special Report Here
Affymax, Inc.(NASDAQ:AFFY) shares gained 4.55% and closed at $1.61. As previously announced, on May 28, 2013, Affymax, Inc. (the “Company”) received a determination letter (the “Determination Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) delisting the Company’s common stock from Nasdaq as of June 6, 2013. Effective on that date, its common stock was immediately eligible for and now trades for quotation on the OTCQB, an electronic quotation service operated by OTC Markets Group Inc. for eligible securities traded over-the-counter.
How Should Investors Trade AFFY After The Recent Volatility? Get Free Report Here
Nuvilex Inc (OTCMKTS:NVLX) shares decreased 2.88% and closed at $0.165 in yesterday’s session. The company on August 7 said it is methodically laying the foundation for what should be a very busy and promising future tomorrow. After making a blockbuster deal to acquire Bio Blue Bird and its worldwide licenses associated with the live-cell encapsulation platform technology to develop treatments for all cancer types, Nuvilex announced this week that it now intends to do the same thing with diabetes.
Is NVLX A Good Buy After The Recent Price Movement? Find Out Here
Elite Pharmaceuticals Inc (OTCBB:ELTP) shares climbed 17.37% to $0.0980. The company on August 5 announced the appointment of longtime industry veteran Nasrat Hakim as President, Chief Executive Officer and member of Elite's board of directors. Elite has also purchased from Mikah Pharma, LLC ("Mikah") twelve approved and one pending Abbreviated New Drug Applications ("ANDAs") to add to Elite's pipeline of products. As part of his employment agreement, Mr. Hakim has elected to receive his salary in restricted common stock in lieu of cash. Jerry Treppel remains Chairman of the Board of Directors.
Additionally, the company announced the Company will host a conference call on Thursday, August 15, 2013 at 3:00 PM EDT to review the first quarter results of operations and provide an update on recent business developments. Company executives will also conduct a question and answer session following their remarks.
Should Investors Rush To Buy ELTP After The Solid Rally? Get Special Report Here
High Rising Stocksis always searching the market every day for massive penny stock runs before they happen so you don't have to.We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)